Nvidia-backed SandboxAQ Introduces AI-Powered Medical Data to Aid Drug Development
PorAinvest
miércoles, 18 de junio de 2025, 9:12 am ET1 min de lectura
NVDA--
SandboxAQ, spun out of Alphabet's Google and backed by Nvidia, has raised nearly $1 billion in venture capital [2]. The company generated about 5.2 million synthetic three-dimensional molecules using Nvidia's chips. This data can train AI models to predict whether a new drug molecule will bind to the target protein, a crucial step before advancing a drug candidate [1].
The approach combines traditional scientific computing techniques with advancements in AI, addressing a long-standing problem in biology [1]. By using synthetic data, SandboxAQ aims to provide results that rival lab experiments but in a fraction of the time [1].
The release of this data could boost Nvidia's business, particularly as demand for AI servers increases. Analysts predict a 20.17% upside for NVDA stock [3].
References:
[1] Reuters. (2025). Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discovery. [URL](https://www.tradingview.com/news/reuters.com,2025:newsml_L6N3SK10Y:0-nvidia-backed-ai-startup-sandboxaq-creates-new-data-to-speed-up-drug-discovery/)
[2] Nellis, S. (2025). Nvidia-backed AI startup SandboxAQ releases data to speed up drug discovery. [URL](https://tech.yahoo.com/ai/articles/nvidia-backed-ai-startup-sandboxaq-120558861.html)
[3] Hackster.io. (2025). Nvidia's robots dream of trajectories not electric sheep with GR00T dreams. [URL](https://www.hackster.io/news/nvidia-s-robots-dream-of-trajectories-not-electric-sheep-with-gr00t-dreams-1f12db16c80f)
SAND--
Nvidia-backed SandboxAQ released new AI medical data, including details on drug connections to proteins, which can help scientists develop new medicines. The data was created using Nvidia's processors, simulating synthetic molecules based on real-world data. This could boost Nvidia's business as demand for AI servers increases, with analysts predicting a 20.17% upside for NVDA stock.
Nvidia-backed AI startup SandboxAQ has released a significant dataset aimed at speeding up the discovery of new medical treatments. The data, generated using Nvidia's processors, simulates synthetic molecules based on real-world data, helping scientists predict how drugs interact with proteins [1].SandboxAQ, spun out of Alphabet's Google and backed by Nvidia, has raised nearly $1 billion in venture capital [2]. The company generated about 5.2 million synthetic three-dimensional molecules using Nvidia's chips. This data can train AI models to predict whether a new drug molecule will bind to the target protein, a crucial step before advancing a drug candidate [1].
The approach combines traditional scientific computing techniques with advancements in AI, addressing a long-standing problem in biology [1]. By using synthetic data, SandboxAQ aims to provide results that rival lab experiments but in a fraction of the time [1].
The release of this data could boost Nvidia's business, particularly as demand for AI servers increases. Analysts predict a 20.17% upside for NVDA stock [3].
References:
[1] Reuters. (2025). Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discovery. [URL](https://www.tradingview.com/news/reuters.com,2025:newsml_L6N3SK10Y:0-nvidia-backed-ai-startup-sandboxaq-creates-new-data-to-speed-up-drug-discovery/)
[2] Nellis, S. (2025). Nvidia-backed AI startup SandboxAQ releases data to speed up drug discovery. [URL](https://tech.yahoo.com/ai/articles/nvidia-backed-ai-startup-sandboxaq-120558861.html)
[3] Hackster.io. (2025). Nvidia's robots dream of trajectories not electric sheep with GR00T dreams. [URL](https://www.hackster.io/news/nvidia-s-robots-dream-of-trajectories-not-electric-sheep-with-gr00t-dreams-1f12db16c80f)
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios